Related references
Note: Only part of the references are listed.Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma
Nikhil C. Munshi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Ciltacabtagene autoleucel, a B-cell maturation antigendirected chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study
Jesus G. Berdeja et al.
LANCET (2021)
CAR T and CAR NK cells in multiple myeloma: Expanding the targets
Urvi A. Shah et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2020)
B cell maturation antigen-specific chimeric antigen receptor T cells for relapsed or refractory multiple myeloma: A meta-analysis
Nico Gagelmann et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2020)
B-cell maturation antigen (BCMA) in multiple myeloma: rationale for targeting and current therapeutic approaches
Nina Shah et al.
LEUKEMIA (2020)
Orchestrating single-cell analysis with Bioconductor
Robert A. Amezquita et al.
NATURE METHODS (2020)
CiteFuse enables multi-modal analysis of CITE-seq data
Hani Jieun Kim et al.
BIOINFORMATICS (2020)
Myeloma CAR-T CRS Management With IL-1R Antagonist Anakinra
Shashidhar S. Jatiani et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2020)
Emerging immunotherapies in multiple myeloma
Urvi A. Shah et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma
Noopur Raje et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
SOHO State of the Art Updates and Next Questions: T-Cell-Directed Immune Therapies for Multiple Myeloma: Chimeric Antigen Receptor-Modified T Cells and Bispecific T-Cell-Engaging Agents
Deepu Madduri et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2019)
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
Daniel W. Lee et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
diffcyt: Differential discovery in high-dimensional cytometry via high-resolution clustering
Lukas M. Weber et al.
COMMUNICATIONS BIOLOGY (2019)
Chimeric antigen receptor T-cell therapy - assessment and management of toxicities
Sattva S. Neelapu et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Pre-clinical validation of B cell maturation antigen (BCMA) as a target for T cell immunotherapy of multiple myeloma
De-Xiu Bu et al.
Oncotarget (2018)
Multiple myeloma
Shaji K. Kumar et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
APRIL and BCMA promote human multiple myeloma growth and immunosuppression in the bone marrow microenvironment
Yu-Tzu Tai et al.
BLOOD (2016)
Evaluation of B cell maturation antigen as a target for antibody drug conjugate mediated cytotoxicity in multiple myeloma
Lydia Lee et al.
BRITISH JOURNAL OF HAEMATOLOGY (2016)
Soluble B-Cell Maturation Antigen Mediates Tumor-Induced Immune Deficiency in Multiple Myeloma
Eric Sanchez et al.
CLINICAL CANCER RESEARCH (2016)
FlowSOM: Using self-organizing maps for visualization and interpretation of cytometry data
Sofie Van Gassen et al.
CYTOMETRY PART A (2015)
Palladium-based mass tag cell barcoding with a doublet-filtering scheme and single-cell deconvolution algorithm
Eli R. Zunder et al.
NATURE PROTOCOLS (2015)
B-cell Maturation Antigen Is a Promising Target for Adoptive T-cell Therapy of Multiple Myeloma
Robert O. Carpenter et al.
CLINICAL CANCER RESEARCH (2013)
Serum B-cell maturation antigen is elevated in multiple myeloma and correlates with disease status and survival
Eric Sanchez et al.
BRITISH JOURNAL OF HAEMATOLOGY (2012)
An anatomically comprehensive atlas of the adult human brain transcriptome
Michael J. Hawrylycz et al.
NATURE (2012)
Share Paper
